Dr. Willmar Schwabe GmbH & Co. KG, commonly known as Schwabe, is a leading player in the herbal medicine industry, headquartered in Karlsruhe, Germany. Founded in 1866, the company has established a strong presence in Europe and beyond, focusing on the development and production of high-quality phytopharmaceuticals. Schwabe is renowned for its innovative approach to herbal remedies, offering a diverse range of products that combine traditional knowledge with modern scientific research. Their core offerings include herbal extracts, dietary supplements, and over-the-counter medications, all distinguished by rigorous quality standards and efficacy. With a commitment to sustainability and a robust portfolio of patented formulations, Schwabe has secured a prominent market position, recognised for its contributions to the field of herbal medicine. The company continues to lead the way in advancing phytotherapy, making significant strides in both research and product development.
How does Dr. Willmar Schwabe GmbH & Co. KG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Dr. Willmar Schwabe GmbH & Co. KG's score of 19 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Dr. Willmar Schwabe GmbH & Co. KG reported total carbon emissions of approximately 6,690,000 kg CO2e for Scope 1 and 2 combined. This figure reflects their commitment to transparency in emissions reporting, although specific Scope 3 emissions data has not been disclosed. The company has made significant strides in reducing its carbon footprint, achieving a reduction of about 6,800,000 kg CO2e compared to 2021 levels. This demonstrates a proactive approach to climate action, although no specific reduction targets or initiatives, such as those from the Science Based Targets initiative (SBTi), have been established or reported. Overall, Dr. Willmar Schwabe GmbH & Co. KG is focused on sustainability and reducing its environmental impact, aligning with industry standards for climate responsibility.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 22,629 | - |
| Scope 2 | 25,565 | - |
| Scope 3 | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Dr. Willmar Schwabe GmbH & Co. KG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

